Roche settles UPenn suit alleging patent infringement by Herceptin, 3 other breast cancer meds
The University of Pennsylvania and Roche’s Genentech unit have settled a lawsuit UPenn originally brought to a Delaware federal court in 2022, which accused the drugmaker of infringing a now-expired patent on methods of tumor treatment pioneered at the university’s Abramson Cancer Center.
The University of Pennsylvania and Roche’s Genentech unit have settled a lawsuit UPenn originally brought to a Delaware federal court in 2022, which accused the drugmaker of infringing a now-expired patent on methods of tumor treatment pioneered at the university’s Abramson Cancer Center.
